Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
140 | Alcoholism: Clinical and Experimental Research | journal | 0.958 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
139 | Anti-Cancer Drug Design | journal | 0.910 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
138 | Birth Defects Research Part B - Developmental and Reproductive Toxicology | journal | 0.410 Q2 | 58 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
137 | Clin-Alert | journal | 0.100 Q4 | 0 | 0 | 47 | 0 | 0 | 47 | 0.00 | 0.00 | 0.00 | |
136 | In Vitro Toxicology: Journal of Molecular and Cellular Toxicology | journal | 0.114 Q4 | 1 | 0 | 3 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
135 | Journal of Medical Marketing | journal | 20 | 28 | 0 | 254 | 0 | 0 | 0.00 | 9.07 | 27.27 | ||
134 | Molecular Therapy | journal | 209 | 170 | 0 | 5838 | 0 | 0 | 0.00 | 34.34 | 28.47 | ||
133 | National Toxicology Program technical report series | journal | 22 | 1 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ||
132 | Journal of Pharmacoepidemiology | journal | 0.107 Q4 | 5 | 4 | 12 | 123 | 1 | 8 | 0.00 | 30.75 | 23.08 | |
131 | American Druggist | journal | 0.102 Q4 | 3 | 0 | 150 | 0 | 3 | 120 | 0.03 | 0.00 | 0.00 | |
130 | Journal of Research in Pharmaceutical Economics | journal | 0.105 Q4 | 6 | 6 | 34 | 149 | 3 | 34 | 0.05 | 24.83 | 28.57 | |
129 | Research Communications in Alcohol and Substances of Abuse | journal | 0.109 Q4 | 5 | 0 | 34 | 0 | 3 | 34 | 0.15 | 0.00 | 0.00 | |
128 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.120 Q4 | 29 | 0 | 24 | 0 | 4 | 22 | 0.17 | 0.00 | 0.00 | |
127 | Pharmaceutical Chemistry Journal | journal | 0.100 Q4 | 39 | 174 | 489 | 2479 | 5 | 489 | 0.01 | 14.25 | 58.53 | |
126 | Journal of Infectious Disease Pharmacotherapy | journal | 0.141 Q3 | 6 | 0 | 29 | 0 | 6 | 28 | 0.21 | 0.00 | 0.00 | |
125 | AAPS Journal | journal | 0.125 Q3 | 132 | 67 | 34 | 1682 | 7 | 34 | 0.21 | 25.10 | 25.00 | |
124 | Clinical Research and Regulatory Affairs | journal | 0.117 Q4 | 18 | 17 | 60 | 310 | 7 | 57 | 0.16 | 18.24 | 11.11 | |
123 | Research Communications in Pharmacology and Toxicology | journal | 0.124 Q4 | 8 | 10 | 61 | 351 | 8 | 61 | 0.05 | 35.10 | 25.00 | |
122 | Adverse Drug Reaction Bulletin | journal | 0.163 Q3 | 8 | 6 | 18 | 175 | 10 | 18 | 0.58 | 29.17 | 11.11 | |
121 | Journal of Pharmacy Technology | journal | 0.116 Q4 | 16 | 63 | 151 | 648 | 10 | 86 | 0.10 | 10.29 | 25.93 | |
120 | Modern Drug Discovery | journal | 0.169 Q3 | 9 | 22 | 23 | 143 | 12 | 23 | 0.52 | 6.50 | 37.93 | |
119 | Pharmacopeial Forum (discontinued) | journal | 0.229 Q3 | 20 | 12 | 50 | 175 | 12 | 50 | 0.24 | 14.58 | 23.81 | |
118 | Pharmaceutical Engineering | journal | 0.196 Q3 | 18 | 46 | 133 | 272 | 13 | 124 | 0.09 | 5.91 | 17.65 | |
117 | Dissolution Technologies | journal | 0.258 Q2 | 36 | 14 | 42 | 79 | 14 | 26 | 0.23 | 5.64 | 14.29 | |
116 | Advances in Drug Research | journal | 0.604 Q2 | 11 | 0 | 9 | 0 | 23 | 9 | 0.00 | 0.00 | 0.00 | |
115 | Pharmaceutical Technology Europe | journal | 0.142 Q3 | 19 | 119 | 130 | 470 | 24 | 111 | 0.18 | 3.95 | 20.51 | |
114 | Neuropsychopharmacology Reports | journal | 22 | 40 | 109 | 1182 | 25 | 108 | 0.21 | 29.55 | 8.16 | ||
113 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.199 Q3 | 34 | 50 | 80 | 975 | 31 | 79 | 0.31 | 19.50 | 36.36 | |
112 | In Vitro and Molecular Toxicology: Journal of Basic and Applied Research | journal | 0.161 Q4 | 22 | 30 | 112 | 830 | 42 | 105 | 0.36 | 27.67 | 32.43 | |
111 | Proceedings of the Western Pharmacology Society | journal | 0.140 Q4 | 25 | 28 | 396 | 397 | 43 | 395 | 0.12 | 14.18 | 33.33 | |
110 | Drug Topics | journal | 0.110 Q4 | 8 | 543 | 1822 | 0 | 52 | 1309 | 0.03 | 0.00 | 47.17 | |
109 | Food and Drug Law Journal | journal | 0.279 Q3 | 23 | 41 | 151 | 4578 | 61 | 151 | 0.41 | 111.66 | 32.26 | |
108 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.448 Q1 | 43 | 60 | 163 | 713 | 66 | 133 | 0.38 | 11.88 | 22.50 | |
107 | Cardiovascular Drug Reviews | journal | 0.322 Q3 | 54 | 26 | 74 | 888 | 69 | 74 | 0.65 | 34.15 | 17.14 | |
106 | Journal of Natural Toxins | journal | 0.359 Q3 | 28 | 31 | 77 | 1250 | 69 | 77 | 0.98 | 40.32 | 28.75 | |
105 | Pharmaceutical Biotechnology | journal | 0.390 Q2 | 28 | 0 | 54 | 0 | 71 | 54 | 1.37 | 0.00 | 0.00 | |
104 | International Journal of Toxicology | journal | 0.256 Q3 | 71 | 55 | 192 | 2029 | 78 | 179 | 0.37 | 36.89 | 29.41 | |
103 | Pharmaceutical Technology | journal | 0.269 Q2 | 42 | 121 | 295 | 825 | 81 | 274 | 0.25 | 6.82 | 26.00 | |
102 | Hospital Pharmacy | journal | 0.139 Q4 | 28 | 167 | 472 | 2262 | 83 | 395 | 0.16 | 13.54 | 38.79 | |
101 | CNS Drug Reviews | journal | 0.282 Q3 | 64 | 23 | 96 | 1454 | 84 | 96 | 0.68 | 63.22 | 14.52 | |
100 | Drug and Chemical Toxicology | journal | 0.238 Q3 | 54 | 44 | 125 | 1220 | 84 | 124 | 0.66 | 27.73 | 30.40 | |
99 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.159 Q4 | 50 | 48 | 131 | 1499 | 85 | 130 | 0.76 | 31.23 | 30.48 | |
98 | American Journal of Pharmaceutical Education | journal | 0.211 Q2 | 78 | 65 | 147 | 1169 | 98 | 147 | 0.68 | 17.98 | 41.56 | |
97 | American Journal of Therapeutics | journal | 0.223 Q3 | 69 | 57 | 175 | 1682 | 98 | 160 | 0.56 | 29.51 | 21.19 | |
96 | Metal-Based Drugs | journal | 0.320 Q3 | 40 | 47 | 122 | 1291 | 104 | 121 | 0.85 | 27.47 | 33.86 | |
95 | Journal of Biochemical and Molecular Toxicology | journal | 0.433 Q2 | 69 | 44 | 85 | 576 | 107 | 85 | 1.26 | 13.09 | 31.45 | |
94 | Journal of Biopharmaceutical Statistics | journal | 1.190 Q1 | 56 | 38 | 132 | 618 | 107 | 127 | 0.64 | 16.26 | 18.18 | |
93 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.350 Q2 | 70 | 0 | 106 | 0 | 115 | 100 | 0.99 | 0.00 | 0.00 | |
92 | Reading Teacher | journal | 1.014 Q1 | 60 | 64 | 177 | 1232 | 117 | 177 | 0.75 | 19.25 | 67.96 | |
91 | Journal of Gene Medicine | journal | 0.638 Q2 | 100 | 53 | 54 | 2263 | 118 | 54 | 2.19 | 42.70 | 32.53 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®